In a randomized trial of patients with T2DM, ARBs were associated with significantly reduced urinary excretion of angiotensinogen in participants overall, and lower albuminuria in participants with high–normal albuminuria, compared with treatment with aliskiren, a direct renin inhibitor [53]. Here, REN is linked to type 2 diabetes mellitus.